This market snapshot provides an analysis of the global market for tissue heart valves. A tissue heart valve is used to treat severe valve disease, caused by degeneration, calcification, or damage to the heart’s valves. These devices are placed during an open-heart (i.e. surgical) procedure. Tissue heart valves are part of the larger heart valve repair and replacement devices market, which also consists of mechanical and transcatheter valves. These products are covered in separate market snapshots.
This market snapshot is intended to provide a high-level overview of the global market for tissue heart valves, with key insights into:
- Unit volumes from 2020 to 2026
- Market forecasts from 2020 to 2026
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- Abbott
- Edwards Lifesciences
